Bielack, SS;
Smeland, S;
Whelan, J;
Marina, N;
Hook, J;
Jovic, G;
Krailo, MD;
... Bernstein, ML; + view all
(2013)
MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization.
Journal of Clinical Oncology
, 31
(15)
10.1200/JCO.2014.60.0734.
![[thumbnail of JCO-2015-Bielack-JCO.2014.60.0734.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) |
PDF
JCO-2015-Bielack-JCO.2014.60.0734.pdf Download (390kB) |
Abstract
EURAMOS-1, an international randomized controlled trial, investigated maintenance therapy with pegylated interferon alfa-2b (IFN-alpha-2b) in patients whose osteosarcoma showed good histologic response (good response) to induction chemotherapy.
| Type: | Article |
|---|---|
| Title: | MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1200/JCO.2014.60.0734 |
| Publisher version: | http://dx.doi.org/10.1200/JCO.2014.60.0734 |
| Language: | English |
| Additional information: | © 2015 by American Society of Clinical Oncology. "The article is Gold Open Access with a CC BY license, but did not appear as open access on the JCO.org Web site. There should have been an open lock icon, a CC BY graphic, and license information under the Abstract and in the sidebar of the article. This has been corrected as of June 8, 2015. Journal of Clinical Oncology apologizes for the mistake." |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1432374 |
Archive Staff Only
 |
View Item |
